Camallergy
PrivateLast Round
Grant
Jan 30, 2023
Total Funding Raised
$5.07M
Company Overview
Camallergy is a biopharmaceutical company that provides innovative, patient-centric treatments to address food allergies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Camallergy Comparables
Compare Camallergy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aravax | 83% | |
| Intrommune Therapeutics | 83% | |
| Prota Therapeutics | 80% | |
Camallergy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 30, 2023 | ||||
| Grant | Mar 9, 2021 | ||||
| Angel | Nov 7, 2017 |
Key People
Founding team and executive leadership
Camallergy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2023
$2.47M grant received from Innovate UK.
Camallergy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Camallergy's valuation, stock price, and market status.